Not currently recruiting at University of California Health
Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa Patients (ENVISION)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Irvine
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Ray Therapeutics, Inc.
- ID
- NCT06460844
- Phase
- Phase 1 Retinitis Pigmentosa Research Study
- Study Type
- Interventional
- Participants
- Expecting 9 study participants
- Last Updated